Shonan Keiiku Hospital

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Saitama Neuropsychiatric Institute日本2
2. Dokkyo Medical University Hospital日本1
3. Teva Pharmaceuticals (United States)美国1
4. Eli Lilly (United States)美国1
5. Fujitsu (Japan)日本1
6. Eli Lilly (Japan)日本1
7. Otsuka (Japan)日本1
8. Tominaga hospital日本1

按月发文

逐年被引

最新文献

1. 1
   Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label StudyDrug Safety202118
2. 2
   A long-term open-label safety study of galcanezumab in Japanese patients with migraineExpert Opinion on Drug Safety202128

高被引文献

1. 1
   A long-term open-label safety study of galcanezumab in Japanese patients with migraineExpert Opinion on Drug Safety202128
2. 2
   Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label StudyDrug Safety202118

主要发表期刊